Expanding Senior Leadership Team to Accelerate 'Make in India, Make for the World' Strategy by TI Medical
In the realm of healthcare, there have been significant developments and changes recently.
Firstly, Sandeep Dogra has been appointed as the Group COO for ShardaCare Healthcity and Sharda Hospital. This appointment marks a new chapter in the leadership of these healthcare institutions.
Moving on, the World Health Organization (WHO) has expanded the Essential Medicines List (EML) to include rapid-acting insulin analogues and GLP-1 receptor agonists. This addition is expected to improve the availability and affordability of these crucial medicines worldwide.
In other news, Medanta, under the leadership of Dr. Naresh Trehan, has expanded its chemotherapy services. The new day-care service is now located in South Delhi, providing easier access to essential cancer treatments for many.
On a different note, GIBS has announced its 10th Annual Conference, focusing on the role of robotics in kidney-preserving cancer care. This conference promises to be a significant event in the field of oncology and robotics.
Lastly, the Department for Promotion of Industry and Internal Trade (DPIIT) has signed an MoU with Pfizer. The exact details of this collaboration are yet to be disclosed, but it is expected to contribute positively to the Indian healthcare sector.
These developments underscore the ongoing progress in healthcare, with innovations in treatment, leadership changes, and collaborations shaping the future of medical care.
Read also:
- Antitussives: List of Examples, Functions, Adverse Reactions, and Additional Details
- Asthma Diagnosis: Exploring FeNO Tests and Related Treatments
- The highly sought-after Škoda Kodiaq vehicle boasts immense popularity this year - we've tracked down outstanding leasing deals tailored just for you
- Anti-vax sentiments rejected by Republican senators with medical backgrounds, countering RFK Jr.'s claims
